4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001104659-19-040969
Options or other derivatives
- Director acquired 9,285 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Haviland Kate Director | 2019-07-18 | Grant or award · Stock Option (right to buy) | +9,285 | 9,285 | D: show line 1 in the form |
Loading xslF345X03/a4.xml…